Yaakov Stern

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Yaakov Stern sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 1 currently recruiting 1 completed upper half by trial count

Yaakov Stern: 2 sponsored US clinical trials, 1 recruiting.

Yaakov Stern sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Mild Cognitive Impairment, with 1 trials.

Mid-pack sponsor footprint

Yaakov Stern is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the Yaakov Stern pipeline

1 recruiting of 2 indexed (50% open); 1 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Mild Cognitive Impairment (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Yaakov Stern: open-pipeline peers nationwide

Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

Yaakov Stern sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60% Total trials Recruiting share Yaakov Stern1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health3ive Labs60 Degrees Pharmaceuticals7 Hills PharmaAbcentra
Yaakov Stern sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Yaakov Stern sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this Yaakov Stern page

2 registered trials is a research-attention snapshot, not an endorsement of Yaakov Stern or any single study.

  • 1 of Yaakov Stern's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Mild Cognitive Impairment is the condition Yaakov Stern studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mild Cognitive Impairment trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Yaakov Stern pipeline card: 2 registered trials from official public datasets.Report a data error.